Brookfield Wealth Solutions Ltd (BNT) 銘柄情報

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Brookfield Wealth Solutions Announces Third Quarter Results and Declares Regular Quarterly Distribution

BROOKFIELD, NEWS, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Brookfield Wealth Solutions (NYSE, TSX: BNT) today announced financial results for the quarter ended September 30, 2024. Sachin Shah, CEO...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Bentley Pharmaceuticals' Stockholders Approve Merger Agreement

Bentley Pharmaceuticals, Inc. (NYSE: BNT) (?Bentley? or the ?Company?) announced today that its stockholders have approved the Agreement and Plan of Merger, dated as of March...

Bentley Pharmaceuticals Notifies NYSE of Intention to Delist Common Stock

Bentley Pharmaceuticals, Inc. (NYSE: BNT) (?Bentley? or the ?Company?) announced today that it notified the New York Stock Exchange (the ?NYSE?) of its intent to delist its...

Bentley Board Approves Spin-off of Drug Delivery Business

The board of directors of Bentley Pharmaceuticals, Inc. (NYSE: BNT) today approved the spin-off of its drug delivery business into a new publicly traded company to be called...

Bentley Pharmaceuticals Announces First Quarter Financial Results

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the first quarter and three months ended March 31, 2008...

Bentley Pharmaceuticals to Release First-Quarter 2008 Financial Results on May 8, 2008

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that management will host a conference call to discuss first-quarter 2008...

Teva to Acquire Bentley Pharmaceuticals

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Bentley Pharmaceuticals, Inc. (NYSE: BNT) announced today that they have entered into a definitive agreement under which...

Bentley Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2007...